The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index; 100 of the 210 sources its claims cite were checked for support.
Navigating the potential of algal peptides: health effects, market applications, and scientific challenges
Open accessAbstract
Introduction Algae-derived bioactive peptides are gaining recognition as functional ingredients offering health benefits and sustainability advantages over conventional proteins. This review aimed to evaluate the current evidence on algal peptides, focusing on their nutritional content, mechanistic actions, health effects, potential for sustainability, and translational challenges.Materials and Methods A comprehensive literature search was conducted across PubMed, Scopus, ScienceDirect, Springer, Elsevier, and Google Scholar. Peer-reviewed studies reporting bioactive peptides derived from microalgae, macroalgae, or Cyanophyceae were included. In vitro, animal, and human intervention studies evaluating molecular mechanisms, metabolic outcomes, or clinical relevance were considered.Results Available evidence shows that algal peptides exert multifunctional bioactivities, including inhibition of angiotensin-converting enzyme and renin, antioxidant and anti-inflammatory effects, modulation of glucose metabolism via α-amylase, α-glucosidase, and DPP-IV inhibition, and regulation of lipid metabolism and adipogenesis. Frequently studied sources included Limnospira, Chlorella, Auxenochlorella, Nannochloropsis, Undaria, Palmaria, Ulva, and Neopyropia. Limited human trials suggest modest but clinically relevant improvements in blood pressure, glycemic control, lipid profiles, and body-weight-related outcomes, primarily using whole algal biomass or extracts. Life-cycle assessments highlight favorable land-use efficiency and carbon sequestration potential, although economic feasibility is constrained by energy-intensive downstream processing.Conclusion Algal-derived peptides demonstrate promising health-promoting effects and align with sustainable nutrition goals. However, their clinical translation is limited by variability in peptide characterization, uncertain bioavailability, and lack of robust human trials. Standardized production methods, improved delivery strategies, comprehensive safety assessments, and well-designed clinical studies are essential to support their application in functional foods and nutraceuticals.
Overview
CoChat Summary
## TL;DR
This is a narrative review of algal-derived bioactive peptides that synthesizes evidence on health effects, sustainability, commercialization, and translational barriers. The paper argues that algal peptides are promising for functional foods and nutraceuticals, but clinical translation is limited by inconsistent characterization, uncertain bioavailability, and a shortage of robust human trials.
## Key findings
- The review reports multifunctional bioactivities of algal peptides, including inhibition of angiotensin-converting enzyme (ACE) and renin, antioxidant and anti-inflammatory effects, glucose-metabolism modulation via α-amylase, α-glucosidase, and DPP-IV inhibition, and regulation of lipid metabolism and adipogenesis.
- Frequently studied algal sources included Limnospira, Chlorella, Auxenochlorella, Nannochloropsis, Undaria, Palmaria, Ulva, and Neopyropia.
- Human intervention evidence in the paper suggests “modest but clinically relevant” improvements in blood pressure, glycemic control, lipid profiles, and body-weight-related outcomes, but the paper notes these studies were primarily on whole algal biomass or extracts rather than isolated peptides.
- Sustainability results cited in the review include favorable land-use efficiency and carbon sequestration potential; microalgal protein yields are reported as 4–15 t per hectare per year, and producing 1 kg of algal protein requires about 2.5 m² of land versus 47–64 m² for pork, 42–52 m² for chicken, and 144–258 m² for beef.
## Methods
- Narrative review design: the authors “aimed to evaluate the current evidence” on algal peptides, focusing on nutritional content, mechanisms, health effects, sustainability, and translational challenges.
- Literature search: a comprehensive search was conducted across PubMed, Scopus, ScienceDirect, Springer, Elsevier, and Google Scholar.
- Inclusion/analysis: peer-reviewed studies of peptides from microalgae, macroalgae, or Cyanophyceae were included, spanning in vitro, animal, and human intervention studies; the paper synthesizes mechanistic, preclinical, clinical, life-cycle, regulatory, and commercial evidence.
## Limitations
- The paper states that clinical translation is limited by variability in peptide characterization, uncertain bioavailability, and a lack of robust human trials.
- It also states that most current evidence is from laboratory and animal models, with limited human intervention data; the text makes evident that many human findings cited are for whole algal biomass or extracts rather than isolated peptides.
- The text makes evident that standardized protocols for hydrolysis, extraction, and peptide characterization are lacking, which hampers reproducibility and cross-study comparison.
- The paper also notes underexplored allergenicity/safety assessment and inconsistent regulatory frameworks; the text makes evident that these issues may limit commercialization and consumer trust.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
80 Valid · 6 Not valid · 67 Not checked · 31 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, microalgae cultivation mounts less stress on arable land and freshwater resources, as they can be grown on non-arable land with a minimum quantity of freshwater or even cultivated in wastewater or seawater [6].”
§ Navigating the potential of algal peptides: health effects, market applications, and scientific challenges > Introduction
What the sources say
- Supportedcites [6] source
The Introduction states that microalgae are more water-efficient than crop plants and can be cultivated on non-arable land with minimal freshwater, or grown in seawater or wastewater. The Algal Cultivation section likewise says their overall water requirement is lower than that of traditional plant-based crops. These passages support the claimed reduction in pressure on arable land and freshwater resources. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In terms of land-use efficiency, algal proteins require substantially less land than both animal- and plant-derived protein sources.”
§ Navigating the potential of algal peptides: health effects, market applications, and scientific challenges > Introduction
What the sources say
- Partly supportedcites [8] sourceExperimental — accuracy not yet measured
The section “Microalgae as a source of proteins and other nutritional components” reports substantially lower land requirements than for pork, chicken and beef proteins. It also reports lower requirements than for *some* plant-based proteins, including soybean and pea protein meals; it does not establish the comparison for plant-derived proteins generally. (LLM, conf=0.86)
- Partly supportedcites [9] sourceExperimental — accuracy not yet measured
Section 3.5 (Proteins; page not provided) says microalgal protein requires less land per kilogram than chicken, pork, and beef protein. It does not compare land use with plant-derived protein sources; its references to tofu and soybean concern amino-acid composition, not land use. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [10] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, controlling inflammation by reducing pro-inflammatory cytokines and blocking inflammatory pathways helps preserve vascular health and prevent hypertension [52].”
§ Navigating the potential of algal peptides: health effects, market applications, and scientific challenges > Health benefits of algal proteins > Impact on hypertension
What the sources say
- Partly supportedcites [52] sourceExperimental — accuracy not yet measured
The Conclusions (page unavailable) say that modulating vascular inflammation with RAS blockers and other antihypertensive drugs improves vascular function and remodeling. The therapeutic-intervention sections also describe reductions in inflammatory effects or markers, but do not establish that reducing pro-inflammatory cytokines and blocking inflammatory pathways prevents hypertension; their treatment discussion concerns vascular protection in hypertensive conditions. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Other promising peptides have been identified from Gracilariopsis lemaneiformis, Mazzaella japonica (Rhodophyta), and Ulva intestinalis (Chlorophyta), each contributing to ACE inhibition and cardiovascular health [58–60].”
§ Navigating the potential of algal peptides: health effects, market applications, and scientific challenges > Health benefits of algal proteins > Impact on hypertension
What the sources say
- Partly supportedcites [58] sourceExperimental — accuracy not yet measured
The Results (§6, page not available) report ACE-inhibitory activity in fractions of a Mazzaella japonica protein hydrolysate and identify peptides in those fractions. The Introduction links ACE inhibition to blood-pressure control, but the paper reports no human or animal studies, so a contribution to cardiovascular health is not established. This citation supports the Mazzaella japonica portion of the multi-source sentence, not claims about the other algae. (LLM, conf=0.86)
- Supportedcites [59] source
The Conclusions report that two peptides from Gracilariopsis lemaneiformis inhibit ACE and reduced blood pressure in spontaneously hypertensive rats. This supports the portion of the multi-citation sentence concerning G. lemaneiformis; this source is not offered as evidence for the other two algae. (LLM, conf=0.94)
- Partly supportedcites [60] sourceExperimental — accuracy not yet measured
For this paper, the relevant part of the multi-citation sentence concerns Ulva intestinalis. The Conclusions (page unavailable in our copy) report two peptides from that species with measured ACE-inhibitory activity, but say that antihypertensive experiments in mice are still needed. The paper therefore supports ACE inhibition and potential cardiovascular relevance, not an established cardiovascular-health benefit. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“consumption of dried wakame powder significantly lowered systolic and diastolic blood pressure in older hypertensive adults [79]”
§ Navigating the potential of algal peptides: health effects, market applications, and scientific challenges > Health benefits of algal proteins > Impact on hypertension
What the sources say
- Supportedcites [79] source
The Subjects and Methods section describes hypertensive patients with a mean age of 71 receiving dried wakame powder. The Abstract reports significant reductions in both systolic and diastolic blood pressure after four and eight weeks, with significant differences from the control group. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
67 more claims · 33 with their cited sources checked
Create a free account to see all 184 claims and every source verdict.
- It may state two separate claims as one. 103
- Probably not a substantial claim. 23
- The quote only partly states this claim. 2
Citations
Cites
Chisti, Y. (2007) · Biotechnology Advances · doi:10.1016/j.biotechadv.2007.02.001 · Cited by 9,524 · cited 1×
“Co-products such as biofuels and residual biomass support SDG 7 (Affordable and Clean Energy), and the inherent CO 2 fixation of microalgae contributes to SDG 13 (Climate Action) by lowering net greenhouse gas emissions [188,189].”
Reducing food's environmental impacts through producers and consumers
Poore, J., & Nemecek, T. (2018) · Science · doi:10.1126/science.aaq0216 · Cited by 6,085 · cited 1×
“Algae also demonstrate superior land efficiency over several plant-based sources, with nuts requiring 7.9 m 2 , pulses 7.3 m 2 , grains 4.6 m 2 , and peas 3.4 m 2 of land per kg of protein [10].”
InfluentialCommercial Applications of Microalgae
Spolaore, P., Joannis-Cassan, C., Duran, E., & Isambert, A. (2006) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.101.87 · Cited by 4,285 · cited 1×
“Additionally, genetic engineering can be used to modify microalgal species, enhancing their diversity and competitiveness [19].”
Obesity and cardiovascular disease: a scientific statement from the American Heart Association
Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000973 · Cited by 3,691 · cited 1×
“Additionally, algal peptides reduce inflammatory cytokines like Tnf-α and il-6, improving insulin sensitivity. collectively, these mechanisms support their potential in managing diabete. by elevated LDL-C and TGs levels, accelerates atherogenesis and plaque instability [113,114].”
Mills, K. T., Bundy, J. D., Kelly, T. N., Reed, J. E., Kearney, P. M., Reynolds, K., Chen, J., & He, J. (2016) · Circulation · doi:10.1161/circulationaha.115.018912 · Cited by 3,531
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066 · cited 2×
“Compounding these issues is chronic low-grade inflammation, characterized by elevated pro-inflammatory cytokines like TNF-α and IL-6, which further disrupt insulin signaling and lipid metabolism [38,140].”
Ambati, R., Phang, S.-M., Ravi, S., & Aswathanarayana, R. (2014) · Marine Drugs · doi:10.3390/md12010128 · Cited by 1,974
An outlook on microalgal biofuels
Wijffels, R. H., & Barbosa, M. J. (2010) · Science · doi:10.1126/science.1189003 · Cited by 1,886 · cited 1×
“Co-products such as biofuels and residual biomass support SDG 7 (Affordable and Clean Energy), and the inherent CO 2 fixation of microalgae contributes to SDG 13 (Climate Action) by lowering net greenhouse gas emissions [188,189].”
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787 · cited 1×
“These chronic conditions are closely interconnected through shared pathological mechanisms such as persistent low-grade inflammation, oxidative stress, and metabolic dysfunction [35].”
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448 · cited 1×
“It plays a pivotal role in the onset and progression of cardiovascular diseases (CVD), and if not properly managed, can lead to serious complications such as heart attacks, strokes, and kidney failure [40–42].”
Research works printed but not linked: 7
- Kovač DJ, Simeunović JB, Babić OB, et al. Algae in food and feed. Food and Feed Research. 2013;40(1):21–32-21-32.
- Habib MAB Parvin M Huntington TC et al. A review on culture production and use of Spirulina as food for humans and feeds for domestic animals; 2008.
- FAO. Dietary protein quality evaluation in human nutrition. Report of an FAQ Expert Consultation. FAO Food Nutr Paper. 2013;92:1–66.
- Park M-Y, Kim E, Kim M-S, et al. Dietary supplementation of sea tangle (Laminaria japonica) improves blood glucose and lipid metabolism in the streptozotocin-induced diabetic rats. Food Sci Biotechnol. 2009;18(3):712–716.
- Dadwar A, Sibi G. In vitro antioxidant and anti-diabetic potential of green microalgae. Chlorella Vulgaris. 2019;13(2):76–88.
- Lee A Cardel M Donahoo WT. Social and environmental factors influencing obesity. In: Feingold KR Anawalt B Boyce A et al. editors. Endotext [Internet]. South Dartmouth (MA): MDText.com Inc.; 2000– [updated 2019 Oct 12]. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK278977/.
- CEVA. Edible Seaweed and Microalgae—Regulatory Status in France and Europe; 2019 Update. Pleubian, France; 2019.
Cited by
Zhang, X., Chen, W., & Chen, H. (2026) · Foods · doi:10.3390/foods15122241 · Cited by 3
“Under Chinese food regulation, ingredients that lack a history of consumption in China are generally classified as new food raw materials and are subject to pre-market safety evaluation and approval before commercialization [73].”
Do, N., Kim, M., Kim, S., Han, D. P., Jang, W., & Kim, Y. (2026) · Nutrients · doi:10.3390/nu18172767
Amin, A., de Oliveira, M. S., Nawaz, T., & Ferreira, O. O. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18060729
“…is well known that results achieved in preclinical models rarely correlate with positive human outcomes due to variations in cutaneous structure, limited bioavailability of peptides at human wound sites, as well as the highly developed evasion mechanisms by polymicrobial biofilm populations [185].”
From ocean to table: Seaweed as a nutrient-dense, health-promoting and sustainable protein source
Jali, S., Harshitha, C., & Balaji, S. (2026) · Algal Research · doi:10.1016/j.algal.2026.104720
Metadata
- Authors
- Khaliq, M., Noor, Z., Moazzam, M., Saeed, F., Tul-Zohra, K., Tariq, E., Muhammad Shahbaz, H., & Khaliq, K.
- Affiliations
- University of Reading (GB)
- University of Veterinary and Animal Sciences (PK)
- Akhtar Saeed Medical and Dental College (PK)
- Department of Nutrition and Health, College of Medicine and Health Sciences, United Arab Emirates University
- Corresponding author
- Khaliq, Muniba
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 2026-03-07
- Volume
- 58
- Issue
- 1
- Pages
- 2637282-2637282
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- PMC
- PMC12973848
- OpenAlex
- W7134186538
- Cited by
- 4
- References
- 240
- Citations by year
- 2026: 4
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Annals of Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CentAUR (University of Reading) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Veterinary and Animal Sciences
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Protein Hydrolysis and Bioactive Peptides
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Keywords
- microalgae, seaweed, bioactive peptides, functional foods, nutraceuticals, angiotensin-converting enzyme inhibition, renin inhibition, antioxidant activity, anti-inflammatory activity, glucose metabolism, lipid metabolism, adipogenesis, blood pressure, glycemic control, life cycle assessment, bioavailability, peptide characterization, sustainable nutrition, Chlorella, Nannochloropsis, Undaria
- MeSH terms
- Bioactive Peptides, Dietary, Animals, Antioxidants, Humans, Peptides, Seaweed, Microalgae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Navigating the potential of algal peptides: health effects, market applications, and scientific challenges. https://app.cochat.ai/papers/10.1080/07853890.2026.2637282
- The paper
- Khaliq, M., Noor, Z., Moazzam, M., Saeed, F., Tul-Zohra, K., Tariq, E., Muhammad Shahbaz, H., & Khaliq, K. (2026). Navigating the potential of algal peptides: health effects, market applications, and scientific challenges. Annals of Medicine. https://doi.org/10.1080/07853890.2026.2637282
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.